BASF Venture Capital and Xiamen C&D are among the limited partners in Longwater Investment’s advanced materials-focused fund, which was already backed by Solvay.

TUM spinout Kiutra has secured seed funding to ramp up operations for its cyrogenic cooling technology, which it regards as the answer to the problem of industrial-scale quantum manufacturing.

HTGF and Consantia Industries have pumped funding into EPFL spinout Neural Concept, which believes its deep learning technology will reduce lead times for manufacturers of physical goods.

Fund manager Neil Woodford has sold his entire stake in Oxford Sciences Innovation, worth close to $70m, as his funds have come under increasing pressure.

Gil Ahrens, formerly head of venture capital and emerging growth coverage at Wells Fargo Securities, is set to reprise his role at Deutsche Bank.

UCL Technology Fund and Parkwalk Advisors have backed UCL and Bristol-founded quantum computing software developer Phasecraft.

Karolinska Development-backed regenerative implant producer OssDsign has booked $15.8m after selling out the original issue for its forthcoming listing, and is now looking to generate up to $2.4m from the overallotment.

Mercia Technologies has returned to back Warwick-founded medtech spinout Medherant, which is preparing to advance its adhesive Tepi Patch technology through the clinic.

The intermediary close of PSL's deep tech-oriented fund comes after additional contributions from the EIF, Bpifrance and Vilmorin & Cie.

GlaxoSmithKline, Novartis and Astellas are among the investors to have celebrated an exit after cancer therapy developer Bicycle secured $60.7m in its initial public offering.